• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于代谢组学的原发性高血压生物标志物鉴定。

Identification of biomarkers for essential hypertension based on metabolomics.

机构信息

Medical College of Soochow University, Suzhou, 215123, PR China.

School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou, 215123, PR China.

出版信息

Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):382-395. doi: 10.1016/j.numecd.2020.11.023. Epub 2020 Dec 2.

DOI:10.1016/j.numecd.2020.11.023
PMID:33495028
Abstract

AIM

Essential hypertension (EH) is one of the most important public health problems worldwide. However, the pathogenesis of EH is unclear and early diagnostic methods are lacking. Metabolomics demonstrates great potential for biomarker discovery and the mechanistic exploration of metabolic diseases.

DATA SYNTHESIS

This review included human and animal metabolomics studies related to EH in the PubMed and Web of Science databases between February 1996 and May 2020. The study designs, EH standards, and reported metabolic biomarkers were systematically examined and compared. The pathway analysis was conducted through the online software MetaboAnalyst 4.0. Twenty-two human studies and fifteen animal studies were included in this systematic review. There were many frequently reported biomarkers with consistent trends (e.g., pyruvate, lactic acid, valine, and tryptophan) in human and animal studies, and thus had potential as biomarkers of EH. In addition, several shared metabolic pathways, including alanine, aspartate, and glutamate metabolism, aminoacyl-tRNA biosynthesis, and arginine biosynthesis, were identified in human and animal metabolomics studies. These biomarkers and pathways, closely related to insulin resistance, the inflammatory state, and impaired nitric oxide production, were demonstrated to contribute to EH development.

CONCLUSIONS

This study summarized valuable metabolic biomarkers and pathways that could offer opportunities for the early diagnosis or prediction of EH and the discovery of the metabolic mechanisms of EH.

摘要

目的

原发性高血压(EH)是全球最重要的公共卫生问题之一。然而,EH 的发病机制尚不清楚,且缺乏早期诊断方法。代谢组学在生物标志物发现和代谢性疾病的机制探索方面具有巨大潜力。

综合数据

本综述纳入了 1996 年 2 月至 2020 年 5 月期间在 PubMed 和 Web of Science 数据库中与 EH 相关的人类和动物代谢组学研究。系统地检查和比较了研究设计、EH 标准和报告的代谢生物标志物。通过在线软件 MetaboAnalyst 4.0 进行途径分析。本系统综述共纳入 22 项人类研究和 15 项动物研究。在人类和动物研究中,有许多经常报道的具有一致趋势的生物标志物(如丙酮酸、乳酸、缬氨酸和色氨酸),因此具有作为 EH 生物标志物的潜力。此外,在人类和动物代谢组学研究中还确定了几个共享的代谢途径,包括丙氨酸、天冬氨酸和谷氨酸代谢、氨酰-tRNA 生物合成和精氨酸生物合成。这些与胰岛素抵抗、炎症状态和一氧化氮产生受损密切相关的生物标志物和途径,被证明有助于 EH 的发生发展。

结论

本研究总结了有价值的代谢生物标志物和途径,为 EH 的早期诊断或预测以及 EH 的代谢机制的发现提供了机会。

相似文献

1
Identification of biomarkers for essential hypertension based on metabolomics.基于代谢组学的原发性高血压生物标志物鉴定。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):382-395. doi: 10.1016/j.numecd.2020.11.023. Epub 2020 Dec 2.
2
Identification of Biomarkers for Preeclampsia Based on Metabolomics.基于代谢组学的子痫前期生物标志物鉴定
Clin Epidemiol. 2022 Mar 19;14:337-360. doi: 10.2147/CLEP.S353019. eCollection 2022.
3
Essential hypertension: A filtered serum based metabolomics study.原发性高血压:基于过滤血清的代谢组学研究。
Sci Rep. 2017 May 19;7(1):2153. doi: 10.1038/s41598-017-02289-9.
4
Metabolomic study for essential hypertension patients based on dried blood spot mass spectrometry approach.基于干血斑质谱分析的原发性高血压患者代谢组学研究。
IUBMB Life. 2018 Aug;70(8):777-785. doi: 10.1002/iub.1885. Epub 2018 Aug 9.
5
Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical Results.代谢组学在小鼠模型中发现缺血性中风生物标志物的应用:与临床结果的比较
Mol Neurobiol. 2021 Dec;58(12):6415-6426. doi: 10.1007/s12035-021-02535-2. Epub 2021 Sep 17.
6
Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review.代谢组学有助于发现缺血性脑卒中的代谢生物标志物和途径:系统评价。
Metabolomics. 2019 Nov 21;15(12):152. doi: 10.1007/s11306-019-1615-1.
7
Microarray Profiling of Circular RNA Identifies hsa_circ_0126991 as a Potential Risk Factor for Essential Hypertension.环状RNA的微阵列分析确定hsa_circ_0126991为原发性高血压的潜在危险因素。
Cytogenet Genome Res. 2019;157(4):203-212. doi: 10.1159/000500063. Epub 2019 May 21.
8
Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review.代谢组学为癫痫的诊断和治疗提供新见解:综述
Neurochem Res. 2022 Apr;47(4):844-859. doi: 10.1007/s11064-021-03510-y. Epub 2022 Jan 24.
9
The Exploration of Fetal Growth Restriction Based on Metabolomics: A Systematic Review.基于代谢组学的胎儿生长受限研究:一项系统综述
Metabolites. 2022 Sep 13;12(9):860. doi: 10.3390/metabo12090860.
10
Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF/MS.基于 UPLC-Q-TOF/MS 的非靶向代谢组学鉴定人尿液中的原发性高血压生物标志物。
Clin Chim Acta. 2018 Nov;486:192-198. doi: 10.1016/j.cca.2018.08.006. Epub 2018 Aug 7.

引用本文的文献

1
Untargeted Metabolic Profiling of Cat Urine and Plasma in Hypertension.高血压猫尿液和血浆的非靶向代谢谱分析
J Vet Intern Med. 2025 Sep-Oct;39(5):e70227. doi: 10.1111/jvim.70227.
2
Plasma Metabolites Link Non-Communicable Diseases to Increased White Matter Hyperintensities.血浆代谢物将非传染性疾病与白质高信号增加联系起来。
CNS Neurosci Ther. 2025 Jul;31(7):e70507. doi: 10.1111/cns.70507.
3
Circulating amino acids and cardiometabolic risk profile in offspring of women with type 1 diabetes: cross-sectional case-control study.
1型糖尿病女性后代的循环氨基酸与心脏代谢风险概况:横断面病例对照研究
Sci Rep. 2025 Jul 1;15(1):21847. doi: 10.1038/s41598-025-07177-1.
4
Advanced Multipurpose Spectroscopic Nanobio-Device for Concurrent Lab-on-a-Chip Label-Free Separation and Detection of Extracellular Vesicles as Key-Biomarkers for Point-of-Care Cardiovascular Disease Diagnostics.用于即时护理心血管疾病诊断的关键生物标志物——细胞外囊泡的片上实验室无标记分离和检测的先进多功能光谱纳米生物装置
Adv Healthc Mater. 2025 Aug;14(21):e2500122. doi: 10.1002/adhm.202500122. Epub 2025 Jun 2.
5
Identification of serum metabolic markers in non-obese hypertensive patients using non-targeted metabolomics.使用非靶向代谢组学鉴定非肥胖高血压患者的血清代谢标志物
Sci Rep. 2025 May 26;15(1):18320. doi: 10.1038/s41598-025-02162-0.
6
Understanding Hypertension: A Metabolomic Perspective.从代谢组学角度理解高血压
Biology (Basel). 2025 Apr 11;14(4):403. doi: 10.3390/biology14040403.
7
Metabolomics of the effects of Yishenjiangya granules in older adults with hypertension.益肾降压颗粒对老年高血压患者影响的代谢组学研究
Front Pharmacol. 2025 Mar 11;16:1491935. doi: 10.3389/fphar.2025.1491935. eCollection 2025.
8
Pathway level metabolomics analysis identifies carbon metabolism as a key factor of incident hypertension in the Estonian Biobank.通路水平代谢组学分析表明,碳代谢是爱沙尼亚生物银行中发生高血压的关键因素。
Sci Rep. 2025 Mar 12;15(1):8470. doi: 10.1038/s41598-025-92840-w.
9
Metabolic Signatures of Blood Pressure and Risk of Cardiovascular Diseases.血压的代谢特征与心血管疾病风险
J Am Heart Assoc. 2024 Dec 3;13(23):e036573. doi: 10.1161/JAHA.124.036573. Epub 2024 Nov 22.
10
Identification of novel hypertension biomarkers using explainable AI and metabolomics.使用可解释人工智能和代谢组学鉴定新型高血压生物标志物。
Metabolomics. 2024 Nov 3;20(6):124. doi: 10.1007/s11306-024-02182-3.